Literature DB >> 25909954

Clinical Neuropathology teaching case 3-2015: female or male brain? Anti-ubiquitin visualizes Barr bodies in hippocampal granule cells which allows the determination of gender in human brains.

Ellen Gelpi1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25909954      PMCID: PMC4542183          DOI: 10.5414/np300877

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


× No keyword cloud information.
Anti-ubiquitin immunohistochemistry is widely used for routine neuropathological work-up of neurodegenerative diseases. The hippocampus is one of the important screening areas of pathology in the human brain. In addition to the detection of dystrophic neurites of amyloid plaques, neurofibrillary tangles, Pick bodies, argyrophilic grains, neuronal cytoplasmic inclusions in fronto-temporal lobar degeneration, glial pathology in progressive supranuclear palsy, corticobasal degeneration, and multiple system atrophy, the hippocampal area has proven very useful for the detection of potential C9orf72 hexanucleotide repeat expansion mutation carriers [1]. In addition to the labelling of pathological structures, anti-ubiquitin immunohistochemistry may also visualize physiological structures that undergo ubiquitination, such as Barr bodies. Barr bodies represent the inactive X chromosome in somatic cells of females [2], therefore they are usually not observed in males except for individuals who have an extra X chromosome as it is the case in Klinefelter syndrome (XXY). Barr bodies are seen at the edge of the nucleus as a small spherical dark condensation attached to the nuclear membrane [2, 3]. They can be observed by means of conventional histochemical stains that visualize the cell nucleus, such as hematoxylin-eosin, Cresyl violet or Papanicolaou stains, or with the help of fluorescent dies [3]. Mechanisms of compactation of Barr bodies include histone H3 methylation and histone H2A ubiquitination [4, 5, 6]. Using anti-ubiquitin immunohistochemistry, Barr bodies can be nicely visualized in the human brain in hippocampal granule cells as illustrated in Figure 1, which allows for the determination of gender in human brains.
Figure 1.

Anti-ubiquitin immunohistochemistry on human hippocampus. A: low magnification of granule cells of dentate gyrus showing diffuse nuclear labelling. B: higher magnification depicts small ubiquitin-positive spherical condensations at the edge of the nuclei (arrows). Nucleoli are not stained.

Conflict of interest

The author reports no conflict of interest.
  6 in total

1.  X-chromosome inactivation: a multi-disciplinary approach.

Authors:  Jeannie T Lee
Journal:  Semin Cell Dev Biol       Date:  2003-12       Impact factor: 7.727

2.  Polycomb group proteins Ring1A/B link ubiquitylation of histone H2A to heritable gene silencing and X inactivation.

Authors:  Mariana de Napoles; Jacqueline E Mermoud; Rika Wakao; Y Amy Tang; Mitusuhiro Endoh; Ruth Appanah; Tatyana B Nesterova; Jose Silva; Arie P Otte; Miguel Vidal; Haruhiko Koseki; Neil Brockdorff
Journal:  Dev Cell       Date:  2004-11       Impact factor: 12.270

Review 3.  Role of Barr bodies obtained from oral smears in the determination of sex.

Authors:  U R Anoop; V Ramesh; P D Balamurali; Oza Nirima; B Premalatha; V P Karthikshree
Journal:  Indian J Dent Res       Date:  2004 Jan-Mar

4.  A morphological distinction between neurones of the male and female, and the behaviour of the nucleolar satellite during accelerated nucleoprotein synthesis.

Authors:  M L BARR; E G BERTRAM
Journal:  Nature       Date:  1949-04-30       Impact factor: 49.962

5.  Methylation of histone H3 at Lys-9 is an early mark on the X chromosome during X inactivation.

Authors:  E Heard; C Rougeulle; D Arnaud; P Avner; C D Allis; D L Spector
Journal:  Cell       Date:  2001-12-14       Impact factor: 41.582

6.  p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS.

Authors:  Safa Al-Sarraj; Andrew King; Claire Troakes; Bradley Smith; Satomi Maekawa; Istvan Bodi; Boris Rogelj; Ammar Al-Chalabi; Tibor Hortobágyi; Christopher E Shaw
Journal:  Acta Neuropathol       Date:  2011-11-19       Impact factor: 17.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.